Progesterone Status Assessment is the clinical evaluation of the circulating concentration and metabolic profile of the steroid hormone progesterone, particularly in relation to its cyclical production in women or its role as a neurosteroid and precursor in both sexes. This assessment is crucial for diagnosing luteal phase defects, evaluating symptoms of anxiety and sleep disturbance, and monitoring the efficacy of hormone replacement therapy. It requires precise timing relative to the menstrual cycle or time of day to be clinically meaningful.
Origin
This diagnostic practice is a core element of reproductive endocrinology, historically focused on fertility and menstrual cycle health, but has expanded to include neuroendocrinology due to progesterone’s significant anxiolytic and neuroprotective properties. The evolution of testing methods, such as salivary or dried urine testing, provides a more accurate reflection of bioavailable levels.
Mechanism
Progesterone exerts its primary effects by binding to specific nuclear receptors, but its assessment also tracks its neuroactive metabolite, allopregnanolone, which positively modulates GABA-A receptors in the brain, promoting calm and sleep. The status assessment helps identify insufficient production, which can compromise the balance with estrogen and diminish its neuroendocrine benefits.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.